VC Funding Trends in Healthcare
Where capital is actually moving.
A live view of VC funding trends in healthcare and life sciences — by therapy area, modality, stage and geography.
"Where is the capital flowing — and what does it mean for our strategy?"
VC capital concentrates in oncology, AI in healthcare, rare disease and metabolic. Mega-rounds shrinking; bridge rounds rising; mid-stage capital tightest.
Healthcare VC has rotated decisively into oncology and AI. Mid-stage capital is the tightest part of the funnel — and where strategic, structured deals win.
What we’re seeing in the data.
Onc + AI dominate allocation
Combined ~40%+ of healthcare VC.
Mid-stage capital tightest
Series B/C feels the squeeze.
Bridge rounds rising
Cap structures stretch existing capital.
How to think about it.
-
01
Track capital by stage
Seed → A → B → C → Pre-IPO.
-
02
Slice by TA + modality
Concentration patterns.
-
03
Map investor activity
Lead frequency, follow patterns.
-
04
Forecast next quarter
Round pipeline + macro signals.
What separates a good answer from a defensible one.
Cost of capital reshapes pace.
IPO window affects late-stage.
Pharma corporate VCs increasingly active.
Where the signal comes from.
Common questions.
Where is the capital squeeze?
Series B/C — most teams need bridge rounds.
How fresh should this be?
Live; quarterly synthesis.
Want this answered on your data?
We build decision systems on top of analyses like this — so the next question takes minutes, not weeks.
Talk to a strategist